請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/82018完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 鍾國彪(Kuo-Piao Chung) | |
| dc.contributor.author | Kai-Wei Chen | en |
| dc.contributor.author | 陳凱威 | zh_TW |
| dc.date.accessioned | 2022-11-25T05:34:10Z | - |
| dc.date.available | 2024-08-01 | |
| dc.date.copyright | 2021-08-19 | |
| dc.date.issued | 2021 | |
| dc.date.submitted | 2021-08-04 | |
| dc.identifier.citation | Althubaiti, A. (2016). Information bias in health research: definition, pitfalls, and adjustment methods. Journal of Multidisciplinary Healthcare, 9, 211-217. doi:10.2147/jmdh.S104807 Amin, M. B., Edge, S., Greene, F., Byrd, D. R., Brookland, R. K., Washington, M. K., . . . Meyer, L. R. (2017). AJCC Cancer Staging Manual (8 ed.): Springer International Publishing. Amin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K., Meyer, L., Gress, D. M., Byrd, D. R., Winchester, D. P. (2017). The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more 'personalized' approach to cancer staging. CA: a cancer journal for clinicians, 67(2), 93–99. https://doi.org/10.3322/caac.21388 An, X., Xu, F., Luo, R., Zheng, Q., Lu, J., Yang, Y., ... Wang, S. (2018). The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer. BMC Cancer, 18(1), 1-10. Arıkan, F., Uçar, M. A., Kondak, Y., Tekeli, A., Kartöz, F., Özcan, K., . . . Coşkun, H. Ş. (2019). Reasons for complementary therapy use by cancer patients, information sources and communication with health professionals. Complementary Therapies in Medicine, 44, 157-161. Bao, T., Cai, L., Snyder, C., Betts, K., Tarpinian, K., Gould, J., . . . Stearns, V. (2014). Patient-Reported Outcomes in Women With Breast Cancer Enrolled in a Dual-Center, Double-Blind, Randomized Controlled Trial Assessing the Effect of Acupuncture in Reducing Aromatase Inhibitor-Induced Musculoskeletal Symptoms. Cancer, 120(3), 381-389. doi:10.1002/cncr.28352 Boyce, C., Neale, P. (2006). Conducting in-depth interviews: A guide for designing and conducting in-depth interviews for evaluation input. Pathfinder International. Monitoring and Evaluation, 2, 1-12. Brounéus, K. (2011). In-depth interviewing. Understanding Peace Reasearch: Methods and Challenges, 130-145. Buckner, C., Lafrenie, R., Dénommée, J., Caswell, J., and Want, D. (2018). Complementary and alternative medicine use in patients before and after a cancer diagnosis. Current Oncology, 25(4), 275-281. Chang, L. C., and Li, I. C. (2004). Patterns of complementary therapy use by homebound cancer patients in Taiwan. Applied Nursing Research, 17(1), 41-47. doi:10.1016/j.apnr.2003.10.006 Chen, K. C., Lu, R., Iqbal, U., Hsu, K. C., Chen, B. L., Nguyen, P. A., ... and Tsai, S. H. (2015). Interactions between traditional Chinese medicine and western drugs in Taiwan: A population-based study. Computer Methods and Programs in Biomedicine, 122(3), 462-470. Chin, C. Y., Chen, Y. H., Wu, S. C., Liu, C. T., Lee, Y. F., and Tsai, M. Y. (2020). Complementary and Alternative Medicine Use in Breast Cancer Patients at a Medical Center in Taiwan: A Cross-Sectional Study. Integrative Cancer Therapies, 19, 10. doi:10.1177/1534735420983910 Chow, W. H., Chang, P., Lee, S. C., Wong, A., Shen, H. M., and Marieke Verkooijen, H. (2010). Complementary and alternative medicine among Singapore cancer patients. Annals Academy of Medicine Singapore, 39(2), 129. Chung, V. C. H., Ma, P. H. X., Lau, C. H., Wong, S. Y. S., Yeoh, E. K., and Griffiths, S. M. (2014). Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies. Health Expectations, 17(5), 622-636. doi:10.1111/j.1369-7625.2012.00794.x Cui, Y., Shu, X. O., Gao, Y., Wen, W., Ruan, Z. X., Jin, F., and Zheng, W. (2004). Use of complementary and alternative medicine by Chinese women with breast cancer. Breast cancer research and treatment, 85(3), 263-270. Devi, B. C. R., Tang, T. S., Corbex, M. (2007). Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Annals of Oncology, 18(7), 1172-1176. Graneheim, U. H., and Lundman, B. (2004). Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Education Today, 24(2), 105-112. Guba, E. G. (1981). Criteria for assessing the trustworthiness of naturalistic inquiries. Educational Technology Research and Development, 29(2), 75-91. Harvie, A., Steel, A., and Wardle, J. (2020). A qualitative study of classical Chinese medicine in community health focusing on self-care: practitioner and staff perspectives. Integrative Medicine Research, 9(1), 42-47. Hashemi, S. M., Rafiemanesh, H., Aghamohammadi, T., Badakhsh, M., Amirshahi, M., Sari, M., . . . Roudini, K. (2020). Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. Breast Cancer, 27(2), 166-178. Hershman, D. L., Unger, J. M., Greenlee, H., Capodice, J. L., Lew, D. L., Darke, A. K., . . . Crew, K. D. (2018). Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer A Randomized Clinical Trial. JAMA, 320(2), 167-176. doi:10.1001/jama.2018.8907 Hsieh, H. F., and Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277-1288. Jurisevic, M. (2020). Complementary and alternative medicine applications in cancer medicine. Traditional Medicine Research, 5(1), 7. Keene, M. R., Heslop, I. M., Sabesan, S. S., and Glass, B. D. (2019). Complementary and alternative medicine use in cancer: A systematic review. Complementary Therapies in Clinical Practice, 35, 33-47. Kelner, M., and Wellman, B. (1997). Health care and consumer choice: medical and alternative therapies. Social Science Medicine, 45(2), 203-212. Kuo, Y. T., Chang, T. T., Muo, C. H., Wu, M. Y., Sun, M. F., Yeh, C. C., and Yen, H. R. (2018). Use of complementary traditional Chinese medicines by adult cancer patients in Taiwan: a nationwide population-based study. Integrative Cancer Therapies, 17(2), 531-541. Lai, J. N., Wu, C. T., and Wang, J. D. (2012). Prescription Pattern of Chinese Herbal Products for Breast Cancer in Taiwan: A Population-Based Study. Evidence-Based Complementary and Alternative Medicine, 2012, 7. doi:10.1155/2012/891893 Lee, Y. C., Chen, Y. H., Huang, Y. C., Lee, Y. F., and Tsai, M. Y. (2020). Effectiveness of combined treatment with traditional Chinese medicine and western medicine on the prognosis of patients with breast cancer. The Journal of Alternative and Complementary Medicine, 26(9), 835-842. Lee, Y. W., Chen, T. L., Shih, Y. R. V., Tsai, C. L., Chang, C. C., Liang, H. H., . . . Wang, C. C. (2014). Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: A population‐based study. Cancer, 120(9), 1338-1344. Lin, Y. H., and Chiu, J. H. (2011). Use of Chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan. Complementary Therapies in Medicine, 19(3), 137-143. Lincoln, Y. S., and Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, Calif.: Sage Publications. Liu, C. H., Tang, W. R., Wang, H. M., and Lee, K. C. (2013). How cancer patients build trust in traditional Chinese medicine. European Journal of Integrative Medicine, 5(6), 495-500. doi:10.1016/j.eujim.2013.08.003 Liu, J., Wang, S., Zhang, Y., Fan, H. T., Lin, H. S. (2015). Traditional C hinese medicine and cancer: History, present situation, and development. Thoracic Cancer, 6(5), 561-569. Liu, S. H., Chuang, W. C., Lam, W., Jiang, Z., and Cheng, Y. C. (2015). Safety surveillance of traditional Chinese medicine: current and future. Drug Safety, 38(2), 117-128. Liu, T. G., Xiong, S. Q., Yan, Y., Zhu, H., Yi, C. (2012). Use of chinese herb medicine in cancer patients: a survey in southwestern china. Evidence-Based Complementary and Alternative Medicine Malterud, K. (2001). Qualitative research: standards, challenges, and guidelines. The Lancet, 358(9280), 483-488. Malterud, K. (2012). Systematic text condensation: a strategy for qualitative analysis. Scandinavian Journal of Public Health, 40(8), 795-805. Markovic, M., Manderson, L., Wray, N., and Quinn, M. (2006). Complementary medicine use by Australian women with gynaecological cancer. Psycho‐Oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer, 15(3), 209-220. Mays, N., and Pope, C. (1995). Qualitative research: rigour and qualitative research. British Medical Journal, 311(6997), 109-112. McCulloch, M., Broffman, M., van der Laan, M., Hubbard, A., Kushi, L., Abrams, D. I., . . . Colford, J. M. (2011). Colon Cancer Survival With Herbal Medicine and Vitamins Combined With Standard Therapy in a Whole-Systems Approach: Ten-Year Follow-up Data Analyzed With Marginal Structural Models and Propensity Score Methods. Integrative Cancer Therapies, 10(3), 240-259. doi:10.1177/1534735411406539 McQuade, J. L., Meng, Z., Chen, Z., Wei, Q., Zhang, Y., Bei, W., . . . Cohen, L. (2012). Utilization of and attitudes towards traditional Chinese medicine therapies in a Chinese cancer hospital: a survey of patients and physicians. Evidence-Based Complementary and Alternative Medicine, 2012. Michalec, B. (2005). Exploring the multidimensional benefits of breast cancer support groups. Journal of Psychosocial Oncology, 23(2-3), 159-179. doi:10.1300/J077v23n02_10 Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., . . . Siegel, R. L. (2019). Cancer treatment and survivorship statistics, 2019. CA: a cancer journal for clinicians, 69(5), 363-385. Mok, T. S. K., Yeo, W., Johnson, P. J., Hui, P., Ho, W. M., Lam, K. C., . . . Zee, B. (2007). A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity. Annals of Oncology, 18(4), 768-774. doi:10.1093/annonc/mdl465 National Cancer Institute. (2015). Cancer Staging. Retrieved from https://www.cancer.gov/about-cancer/diagnosis-staging/staging National Cancer Institute. (2021). Definition of early-stage breast cancer. Retrieved from https://www.cancer.gov/publications/dictionaries/cancer-terms/def/early-stage-breast-cancer National Institutes of Health. (2019). National Center for Complementary and Integrative Health (NCCIH). Retrieved from https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-center-complementary-integrative-health-nccih Norton, T. R., Manne, S. L., Rubin, S., Carlson, J., Hernandez, E., Edelson, M. I., . . . Bergman, C. (2004). Prevalence and Predictors of Psychological Distress Among Women With Ovarian Cancer. Journal of Clinical Oncology, 22(5), 919-926. doi:10.1200/jco.2004.07.028 O. Nyumba, T., Wilson, K., Derrick, C. J., and Mukherjee, N. (2018). The use of focus group discussion methodology: Insights from two decades of application in conservation. Methods in Ecology and evolution, 9(1), 20-32. PU, C. Y., Lan, V., Lan, C. F., and Lang, H. C. (2008). The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment. European Journal of Cancer Care, 17(4), 340-349. Qian, H., and Hou, L. (2016). Psychological impact of revealing a diagnosis of lung cancer to patients in China. Journal of Thoracic Disease, 8(10), 2879-2884. Retrieved from https://jtd.amegroups.com/article/view/10050 Joseph Raz, Intention and Motivation, King's college London Dickson Poon school of law legal studies research paper No. 2017-34; Oxford legal studies research paper No. 45/2017; Columbia public law research paper No. 14-556 (2017). Robinson, O. C. (2014). Sampling in Interview-Based Qualitative Research: A Theoretical and Practical Guide. Qualitative Research in Psychology, 11(1), 25-41. doi:10.1080/14780887.2013.801543 Saks, M., and Allsop, J. (2012). Researching health: Qualitative, quantitative and mixed methods: Sage. Shen, H. S., and Wen, S. H. (2018). Effect of early use of Chinese herbal products on mortality rate in patients with lung cancer. Journal of ethnopharmacology, 211, 1-8. Shi, Q., Liu, S., Li, W., Zong, S., Han, S., Yang, W., . . . Hou, F. (2017). Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study. Oncotarget, 8(8), 13488. Singer, S., Das-Munshi, J., and Brähler, E. (2010). Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Annals of Oncology, 21(5), 925-930. Smithson, J., Britten, N., Paterson, C., Lewith, G., and Evans, M. (2012). The experience of using complementary therapies after a diagnosis of cancer: a qualitative synthesis. Health, 16(1), 19-39. Standish, L. J., Sweet, E., Naydis, E., and Andersen, M. R. (2013). Can we demonstrate that breast cancer “integrative oncology” is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics. Integrative Cancer Therapies, 12(2), 126-135. Stapleton, J. M., Mullan, P. B., Dey, S., Hablas, A., Gaafar, R., Seifeldin, I. A., ... Soliman, A. S. (2011). Patient‐mediated factors predicting early‐and late‐stage presentation of breast cancer in Egypt. Psycho‐Oncology, 20(5), 532-537. Tao, W. W., Jiang, H., Tao, X. M., Jiang, P., Sha, L. Y., and Sun, X. C. (2016). Effects of acupuncture, Tuina, Tai Chi, Qigong, and traditional Chinese medicine five-element music therapy on symptom management and quality of life for cancer patients: a meta-analysis. Journal of Pain and Symptom Management, 51(4), 728-747. Vaismoradi, M., Turunen, H., and Bondas, T. (2013). Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nursing Health Sciences, 15(3), 398-405. Vodermaier, A., Linden, W., MacKenzie, R., Greig, D., and Marshall, C. (2011). Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. British Journal of Cancer, 105(12), 1814-1817. doi:10.1038/bjc.2011.503 Wang, J. W., Yang, Z. Q., Liu, C., Chen, S. J., Shen, Q., Zhang, T. R., . . . Yu, J. M. (2015). Cancer survivors’ perspectives and experience on western medicine and traditional Chinese medicine treatment and rehabilitation: A Qualitative Study. Patient Preference and Adherence, 9, 9. Wang, K. L., Chen, Q., Shao, Y. Y., Yin, S. S., Liu, C. Y., Liu, Y. M., . . . Yu, H. Y. (2021). Anticancer activities of TCM and their active components against tumor metastasis. Biomedicine Pharmacotherapy, 133. doi:10.1016/j.biopha.2020.111044 Wu, H. A., Chen, C. H., Hsieh, M. H., Wu, Y. C., Chiu, J. P., Huang, C. J., Hsu, C. H. (2021). The Benefit of Enhanced Daycare of Traditional Chinese Medicine for Cancer Treatment Related Adverse Events: A Retrospective Study of Medical Records. Integrative Cancer Therapies, 20, 15347354211025634. Constitution of the World Health Organization. (1946). American journal of public health and the nation's health, 36(11), 1315–1323. https://doi.org/10.2105/ajph.36.11.1315 Yeh, Y. H., Chou, Y. J., Huang, N., Pu, C., and Chou, P. (2016). The trends of utilization in traditional Chinese medicine in Taiwan from 2000 to 2010 A population-based study. Medicine, 95(27). doi:10.1097/md.0000000000004115 Yu, H., Wang, S., Liu, J., and Lewith, G. (2012). Why do cancer patients use Chinese Medicine?—A qualitative interview study in China. European Journal of Integrative Medicine, 4(2), e197-e203. Yu, T. H., Chung, K. P., Tung, Y. C., and Tsai, H. Y. (2018). Insight into Patients’ Experiences of Cancer Care in Taiwan: An Instrument Translation and Cross-Cultural Adaptation Study. International Journal of Environmental Research and Public Health, 15(8), 1772. 丁志音(2003)。誰使用了非西醫的補充與另類療法? 社會人口特質的無區隔性與健康需求的作用。台灣公共衛生雜誌,22(3),155-166 中央健康保險署(2020a)。全民健保醫療費用申報狀況。 Retrieved from https://www.nhi.gov.tw/Content_List.aspx?n=D529CAC4D8F8E77B topn=23C660CAACAA159D 中央健康保險署(2020b)。特約醫事機構門診核付狀況-按西、中、牙醫及縣市別。Retrieved from https://dep.mohw.gov.tw/DOS/lp-4078-113.html 王惠珀(2011)。從用藥安全到用藥安全環境建構。藥學雜誌,27(1),2-9 王惠珀(2015)。藥政管理一國兩制的隱憂。藥學雜誌,31(3),2-7 王鵬惠、顏明賢、吳香達(2015)。乳房攝影及乳癌篩檢。婦癌醫學期刊(42),37-40。 台灣癌症登記中心(2021)。台灣10大癌症103-107年新發個案存活率。 Retrieved from http://tcr.cph.ntu.edu.tw/uploadimages/Survival_103_107.pdf 行政院性別平等會(2021)。各類醫事人員性別統計。 Retrieved from https://www.gender.ey.gov.tw/gecdb/Stat_Statistics_DetailData.aspx?sn=nBT88TUWFkuuUVpqGWj2ow%40%40 余萬能(2008)。整編中藥法規解釋令函,建立中藥法規資料庫研究計畫。中醫藥年報,26(3) 余萬能(2012)。中醫健保處方調劑之法制問題。全國律師,16(12),16-24。 吳宿真、吳淑娟、陳朝宗、林舜穀(2017)。藥師判斷性服務於中醫領域實例分析。中醫藥研究論叢,20(2),9-19。doi:10.6516/tjtcm.2017.20(2)09 吳麗珍、黃惠滿、李浩銑(2014)。方便取樣和立意取樣之比較。護理雜誌,61(3),105-111 李丞華、周穎政、陳龍生、張鴻仁(2004)。全民健保中醫門診利用率及其影響因素。台灣公共衛生雜誌,23(2),100-107 李和蓁、郭晨榆、吳秉富、李穎俊、林舜穀(2017)。中醫對癌症的長期治療成效。台北市中醫醫學雜誌,23(4),1-5 杜穎純(2018)。濃縮中藥與水藥的差別。消費者報導雜誌(451),21-25 周平、楊弘任、林本炫(2007)。質性研究方法的眾聲喧嘩。高雄復文 林金定、嚴嘉楓、陳美花(2005)。質性研究方法: 訪談模式與實施步驟分析。身心障礙研究季刊,3(2),122-136 林美珠、李玉春(2003)。全民健保中醫門診總額支付制度實施前醫療服務品質之研究。台灣公共衛生雜誌,22(3),204-216 林恭儀(2008)。癌症患者的中醫就醫行為。國立臺灣大學預防醫學研究所碩士論文,台北市。取自https://hdl.handle.net/11296/eztp9d 林健蓉、謝宗運、張慈文(2017)。乳癌之中西醫病機與預防。中醫藥雜誌,28(2),11-27 林舜穀、陳旺全(2018)。中醫實證-運用科學證據,解決臨床問題。台北市中醫醫學雜誌,24(1),29-35。doi:10.6718/tjcm.201803_24(1).0006 邱秀渝、王正旭、謝政毅、蘇連瓔、戚繼玲、呂嘉玲(2016)。由癌症病友支持的領航談台灣癌症資源中心的服務。腫瘤護理雜誌,16,5-20 邱惠英、林佑樺、王金洲、陳婉宜、張晃智、林孟志(2016)。肺癌化學治療後病人照護需求與相關因素之探討。護理雜誌,63,P62-72 施純全(2015)。中醫發展政策建言。北市中醫會刊,21(1),32-36 洪志成、廖梅花(2003)。焦點團體訪談。嘉義: 濤石文化事業有限公司。P88-89,156-169 胡幼慧主編(1996)。質性研究: 理論,方法及本土女性研究實例。台北: 巨流 翁麗雀(2001)。乳癌病人之就醫行為。護理雜誌,48(3),71-74 酒小蕙(2016)。推動四癌篩檢策略分析。中華職業醫學雜誌,23(4),253-258。 國民健康署(2019)。乳癌防治。 Retrieved from https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=614 pid=1124 國民健康署(2020)。中華民國107年癌症登記報告。Retrieved from https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=269 pid=13498 張玉珠、王玉眞、陳海焦(2008)。癌症病患參加支持團體之經驗。長庚護理,19(2),151-161 張育誠、吳鴻昌、李清潭(2015)。意義,脈絡,反身性: 質性研究的科學性與正當性。商略學報,7(2),71-88 張芬芬(2007)。後現代質性研究: 特徵及其對課程研究的蘊義。課程與教學,10(3),31-48 張芬芬(2010)。質性資料分析的五步驟: 在抽象階梯上爬升。初等教育學刊(35),87-120 張苙雲(1998)。「逛醫師」的邏輯:求醫歷程的分析。臺灣社會學刊(21),59-87 張雪鳳、黃靖、徐惠禎(2004)。縮短中醫門診病患候診時間之專案。慈濟護理雜誌,3(1),81-88。doi:10.6974/TCNJb.200403.0081 張賢哲、蔡貴花、蕭晴穎(2011)。臺灣河洛中藥文化。中醫藥雜誌,22(1 2),77-93 梁淑媛、莊宇慧、吳淑芳(2012)。內容分析技巧在護理質性資料之初步應用。護理雜誌,59(5),84-90 章美英、許麗齡(2006)。質性研究-焦點團體訪談法之簡介與應用。護理雜誌,53(2),67-72 章美英、劉介宇、朱美綺、吳宗懋、陳美麗、朱梅綾(2013)。國人使用輔助與替代醫療現況及其相關因素: 2011 年全國性調查分析。台灣公共衛生雜誌,32(1),85-99 許中華(2017)。寬心癌友 : 中醫調理 癌友寬心 不讓復發找上你。臺北市 :天下生活出版 郭玉霞主編(2009)。質性硏究資料分析 : NVivo 8活用寶典。臺北市: 高等教育出版 郭淑珍(2018)。醫療專業者對於癌症患者使用非西醫補充與另類醫療的看法。人文社會與醫療學刊(5),53-77 郭淑珍(2020)。癌症患者使用中醫的經驗: 以乳癌病患為例。人文社會與醫療學刊(7),39-60 陳民虹(2005)。乳癌的流行病學特徵及危險因子。澄清醫護管理雜誌,1(1),30-38 陳旺全(2005)。中醫對癌症末期疼痛的控制。中醫藥研究論叢,8(1),1-12。 陳俊良(2010)。癌症的中醫輔助治療。腫瘤護理雜誌,10(2),1-7 陳建宏、吳修安、謝明憲、吳勇璋、邱榮鵬、許中華(2020)。肺癌患者經中醫門診延長照護後癌症治療副作用的改善成效。中醫內科醫學雜誌,18(2),1-11 陳建宏、許中華(2015)。中醫師在安寧緩和醫療的角色與展望。北市醫學雜誌,12,168-172 陳婉伶、蔡嘉一、黃怡嘉(2015)。比較中醫期刊文獻與台灣健保資料庫乳癌研究之用藥差異。中西整合醫學雜誌,17(3),17-24 馮紀新、邱詩方、伍崇弘、陳建仲(2019)。中醫專科醫師制度的建立與推動之研究。中醫藥研究論叢,22(1),243-253 黃怡超(2018)。中醫藥在台灣發展之現況與展望。台北市中醫醫學雜誌,24(1),1-3 黃威翔(2016)。探討台灣地區中西醫門診複向求醫行為及影響因素。長榮大學醫務管理學系(所)碩士論文,台南市。取自https://hdl.handle.net/11296/775j33 黃碧松、賴鎮源(2014)。乳癌臨床診治思維。傳統醫學雜誌,25(1),63-91 黃鳳玉、許中華(2016)。癌症病人放化療後外感之中醫治療。北市中醫會刊,22(1),41-46 楊晉瑋、楊賢鴻、吳宜鴻、喬聖琳、陳星諭、陳俊良(2012)。台灣中醫住院對癌症病患的輔助治療之評估。中醫藥雜誌,23(2),153-163 楊淑婷、洪裕強(2017)。癌症患者抑鬱症中醫治療文獻回顧。中醫藥研究論叢,20(2),33-40 葉永文(2010)。科學化?西醫化?台灣中醫發展的醫政分析。社會分析(1),97-130 葉明憲(2020)。癌症疾病中醫治療之研究。中國醫藥大學中醫學系博士班博士論文,台中市。 取自https://hdl.handle.net/11296/43wjsa 廖慧伶、馬作繈、邱晏麟、何玉鈴、張腎哲、林宜信、張永動(2006)。臺灣地區民眾之中藥房消費行為及相關影響因素探討。醫務管理期刊,7(3),323-341doi:10.6174/jhm2006.7(3).323 廖麗蘭、許中華(2017)。乳癌中西醫療法的探討。中醫內科醫學雜誌,15(1),11-27 熊誼芳、蔡秀鸞、王怡人、李英芬(2016)。癌症病人害怕疾病進展之因素,評估與照護。腫瘤護理雜誌,16,43-56 趙玉環、李姿儀、許樹珍(2018)。從多重理論模式綜觀乳癌倖存者過渡期照護之影響因素與介入策略。護理雜誌,65(1),83-89 doi:10.6224/jn.201802_65(1).11 劉世閔(2018)。NVivo 11 Plus 的社交網絡分析在個案研究之運用: 以七次國編版國語教科書的負面人物為例。臺灣教育評論月刊,7(1),317-335 蔡文正(2007)。民眾對中醫藥的認知度,信賴度,使用度及其相關因素之探討。中醫藥年報,27(4) 衛生福利部(2020a)。108年國人死因統計結果。 Retrieved from https://www.mohw.gov.tw/cp-4631-54482-1.html 衛生福利部(2020b)。十大癌症發生率。 Retrieved from https://dep.mohw.gov.tw/DOS/cp-1720-7336-113.html 衛生福利部(2020c)。主要癌症死亡原因。 Retrieved from https://dep.mohw.gov.tw/dos/cp-1720-9687-113.html 衛生福利部(2020d)。健保門診件數與申報費用—中醫。臺北市 Retrieved from https://dep.mohw.gov.tw/dos/cp-1720-9845-113.html 衛生福利部統計處(2021)。109年藥政管理。臺北市 賴榮年、吳建東、王榮德(2013)。台灣乳癌婦女 1998-2008 年間的中藥使用率及模式分析。中醫藥雜誌,24(1),13-23 謝麗鳳、莊紫雲、劉淑珍、蔡欣玲、陳美碧(2011)。癌症病人化療期間居家護理指導及電話諮詢成效。腫瘤護理雜誌,11(1),23-35 顏沛滋、劉景萍、蘇籹銦(2016),癌症病人治療旅程中的陪伴者~癌症資源中心服務。腫瘤護理雜誌,16,21-30 Sharan B. Merriam, Elizabeth J. Tisdell(2018)。質性研究:設計與施作指南 (邱炳坤等人翻譯)。臺北市:五南 Speziale, H. S., Carpenter, D. R.(2003)。護理質性硏究 : 促進人道主義的權威(鍾玉娟、李智峰、張莉琴翻譯)。臺北市:五南 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/82018 | - |
| dc.description.abstract | 背景與目的:癌症位居國人死因之首迄今已三十餘年,臺灣的癌症病人在診斷後除常規醫療之外,也經常併用中醫藥。而早期與晚期癌症病人的中醫藥使用意向與經驗之差異,可能影響照護需求及其臨床照護結果,卻未曾探討。本研究以乳癌為例,探討癌症早期和晚期病人在中醫藥的使用意向與經驗之差異,及其對中醫藥的照護需求影響因素,此外也探討中醫師對於此議題的觀點。 研究方法:採用質性研究設計,以半結構式訪談大綱進行訪談。透過方便取樣招募乳癌病人進行焦點團體訪談,另採立意取樣輔以滾雪球方式進行中醫師個人深度訪談收集資料。資料之分析使用內容分析法,透過NVivo 12輔助質性資料之分析,計算出特定編碼出現的頻率,並加以歸納呈現結果。 研究結果:乳癌病人焦點團體訪談進行5場,共有12位早期、7位晚期乳癌病人受訪者,中醫師個人深度訪談共有7位受訪者。早期與晚期之乳癌病人在癌症診斷後多會出現負面的心理衝擊,中醫藥使用之主要意向是受到副作用所困擾並希望調整體質,中醫藥之資訊來源是透過親友的推薦為主,在中醫藥使用的經驗中,面對西醫方面乳癌病人未必會向西醫告知中醫藥使用情形,而在中醫藥的照護之下,得到副作用改善、體能增強與心靈安定是主要的改變,對於現階段的中醫藥照護大致滿意,但仍對候診時間、用藥安全與便利性的改善有所期望;在早期乳癌病人則另有預防癌症復發或轉移的中醫藥使用意向,中醫藥使用的經驗中,會較正向與西醫討論中醫藥的使用,感受到較多中醫藥對腫瘤的控制與預防之效且提升生活品質等,並期待中醫藥能發展科學化與諮詢服務;而晚期病人之中醫藥使用意向以受副作用困擾之提及最為頻繁,中醫藥使用經驗中,中醫藥使用較不易被西醫接納,雖能感受中醫藥照護對副作用之改善,但未必能全然滿足照護需求,且對於癌症日間延長照護與健保涵蓋範圍有更多期望。影響早期與晚期乳癌病人促使、維持與阻礙其中醫藥照護需求之因素中,早期病人有更多面向的因素會影響中醫藥之使用。中醫師則認為乳癌病人在中醫藥的照護中,西醫治療的情形、病人的病情、就醫意向與目標等因素會受到期別的影響而有所不同,乳癌病人個別的體質、求醫心態與整體療效之於期別的影響則未有一致觀點,對於改進用藥的模式、中醫藥科學與實證化、健保與健康政策的發展是中醫師對癌症中醫藥照護的建議與期盼。 結論與建議:早期和晚期的乳癌病人在中醫藥使用意向與經驗,以及對中醫藥照護需求之影響因素不盡然相同,中醫師亦認為不同期別的癌症病人可能影響其中醫藥之照護。後續研究可以收集更多元的樣本來源,並更細部比較各期別之間的差異;建議健康政策制定者應建立完備的照護資源與方案,尤其強化早期病人對於腫瘤復發或轉移之中醫藥照護需求,以及更積極介入晚期病人對於西醫治療後的副作用症狀且以延長存活與提升生活品質為目標,並參考本研究結果與臨床實證做為依據,整合中西醫之癌症照護,給予早期或晚期之癌症病人適切的照護資源導引,以避免潛在風險而提升癌症之治療結果與照護品質。 | zh_TW |
| dc.description.provenance | Made available in DSpace on 2022-11-25T05:34:10Z (GMT). No. of bitstreams: 1 U0001-0308202113274400.pdf: 2744490 bytes, checksum: 3bf895c0932c8c4922df55bf5dbab253 (MD5) Previous issue date: 2021 | en |
| dc.description.tableofcontents | 誌謝 i 中文摘要 ii Abstract iii 目錄 iv 表目錄 vi 圖目錄 vii 第一章 緒論 1 第一節 研究背景與動機 1 第二節 研究目的 3 第二章 文獻回顧 4 第一節 癌症的流行病學 4 第二節 癌症病人補充與替代療法或中醫藥之使用 6 第三節 癌症病人的中醫藥使用情形 8 第四節 癌症診斷期別使用中醫藥的差異 10 第五節 乳癌族群在中醫藥的特性 17 第六節 文獻小結 18 第三章 研究方法 19 第一節 研究設計與對象 19 第二節 資料收集 20 第三節 資料處理與分析 22 第四節 研究嚴謹度 24 第五節 研究倫理 27 第四章 研究結果 28 第一節 訪談與受訪者組成背景 28 第二節 乳癌病人中醫藥使用意向與經驗 31 第三節 乳癌病人對中醫藥照護需求的影響因素 69 第四節 中醫師對乳癌照護及乳癌不同期別照護的觀點與建議 71 第五章 討論 107 第一節 研究資料收集與資料分析之討論 107 第二節 乳癌病人中醫藥使用意向與經驗之討論 111 第三節 乳癌病人對中醫藥照護需求的影響因素之討論 122 第四節 中醫師對乳癌照護及乳癌不同期別照護觀點與建議之討論 124 第五節 研究限制 138 第六章 結論與建議 140 第一節 研究結論 140 第二節 建議 143 參考文獻 145 附錄 156 附錄一、 文本資料分析過程示例 156 附錄二、 人體研究倫理審查計畫執行許可書 157 附錄三、 中醫師受訪者同意書 159 附錄四、 乳癌病人受訪者同意書 165 附錄五、 質性研究信實度的策略及其做法 171 | |
| dc.language.iso | zh-TW | |
| dc.subject | 期別 | zh_TW |
| dc.subject | 使用意向與經驗 | zh_TW |
| dc.subject | 中醫藥 | zh_TW |
| dc.subject | 乳癌 | zh_TW |
| dc.subject | 癌症 | zh_TW |
| dc.subject | breast cancer | en |
| dc.subject | cancer | en |
| dc.subject | traditional Chinese medicine | en |
| dc.subject | stages | en |
| dc.subject | intention of utilization and experience | en |
| dc.title | 癌症早期與晚期病人對中醫藥使用意向與經驗之初探:以乳癌為例 | zh_TW |
| dc.title | Exploring the intention of utilization and experience toward traditional Chinese medicine among cancer patients in early and late stages:An example of breast cancer | en |
| dc.date.schoolyear | 109-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 許中華(Hsin-Tsai Liu),胡文郁(Chih-Yang Tseng) | |
| dc.subject.keyword | 癌症,中醫藥,期別,使用意向與經驗,乳癌, | zh_TW |
| dc.subject.keyword | cancer,traditional Chinese medicine,stages,intention of utilization and experience,breast cancer, | en |
| dc.relation.page | 171 | |
| dc.identifier.doi | 10.6342/NTU202102037 | |
| dc.rights.note | 同意授權(限校園內公開) | |
| dc.date.accepted | 2021-08-04 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 健康政策與管理研究所 | zh_TW |
| dc.date.embargo-lift | 2024-08-01 | - |
| 顯示於系所單位: | 健康政策與管理研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-0308202113274400.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 2.68 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
